CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,891,000 | +335.7% | 1,428,200 | +2741.3% | 1.65% | +2598.4% |
| Q4 2017 | $3,418,000 | -32.3% | 50,266 | -18.0% | 0.06% | -19.7% |
| Q3 2017 | $5,050,000 | +399.5% | 61,300 | +467.6% | 0.08% | +406.7% |
| Q2 2017 | $1,011,000 | +33.9% | 10,800 | -9.0% | 0.02% | +36.4% |
| Q1 2017 | $755,000 | +70.0% | 11,869 | +18.7% | 0.01% | +37.5% |
| Q4 2016 | $444,000 | +2.5% | 10,000 | -16.8% | 0.01% | +14.3% |
| Q3 2016 | $433,000 | +104.2% | 12,015 | +8.7% | 0.01% | +75.0% |
| Q1 2016 | $212,000 | -52.7% | 11,057 | +116.8% | 0.00% | -33.3% |
| Q2 2015 | $448,000 | -76.8% | 5,100 | -88.0% | 0.01% | -76.0% |
| Q3 2014 | $1,928,000 | +10.6% | 42,500 | +1.0% | 0.02% | +19.0% |
| Q2 2014 | $1,743,000 | – | 42,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |